Bioness, Valencia, California, announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) to market its L300® Foot Drop System to pediatric patients and their caregivers. This is the first FDA-cleared neurostimulation device of this kind for use with children.